Updated on 25 September 2026
End-to-End ASO Drug Discovery with LuxiAP™
About
Luxna Biotech supports ASO drug discovery from initial design and screening through lead optimization and preclinical evaluation. Our LuxiAP™ platform combines proprietary nucleic acid chemistry with practical experience gained through collaborations with pharmaceutical companies.
ASO optimization is a particular strength. We work with partners to improve the activity, duration of effect, and safety profile of candidates according to the needs of each program. We welcome discussions with companies seeking a research partner for a new ASO program or looking to optimize an existing candidate.